These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8735204)

  • 21. Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection.
    Schatz DS; Saria A
    Pharmacology; 2000 Jan; 60(1):51-6. PubMed ID: 10629444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations and side effects in psychiatric patients during risperidone therapy.
    Olesen OV; Licht RW; Thomsen E; Bruun T; Viftrup JE; Linnet K
    Ther Drug Monit; 1998 Aug; 20(4):380-4. PubMed ID: 9712460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
    Saito M; Yasui-Furukori N; Nakagami T; Furukori H; Kaneko S
    J Clin Psychopharmacol; 2005 Dec; 25(6):527-32. PubMed ID: 16282832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtherapeutic risperidone serum concentrations in an adolescent during hemodialysis: a pharmacological puzzle.
    Railton CJ; Kapur B; Koren G
    Ther Drug Monit; 2005 Oct; 27(5):558-61. PubMed ID: 16175125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.
    Huang F; Lasseter KC; Janssens L; Verhaeghe T; Lau H; Zhao Q
    J Clin Pharmacol; 2002 Dec; 42(12):1341-51. PubMed ID: 12463729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
    Spina E; Avenoso A; Facciolà G; Salemi M; Scordo MG; Giacobello T; Madia AG; Perucca E
    Ther Drug Monit; 2000 Aug; 22(4):481-5. PubMed ID: 10942191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS.
    Cabovska B; Cox SL; Vinks AA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):497-504. PubMed ID: 17344104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of venlafaxine on the pharmacokinetics of risperidone.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    J Clin Pharmacol; 1999 Mar; 39(3):297-309. PubMed ID: 10073330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma.
    Bhatt J; Subbaiah G; Singh S
    Rapid Commun Mass Spectrom; 2006; 20(14):2109-14. PubMed ID: 16775814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV.
    Mandrioli R; Mercolini L; Lateana D; Boncompagni G; Raggi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):167-73. PubMed ID: 21183412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma protein binding of risperidone and its distribution in blood.
    Mannens G; Meuldermans W; Snoeck E; Heykants J
    Psychopharmacology (Berl); 1994 May; 114(4):566-72. PubMed ID: 7531854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection.
    Aravagiri M; Marder SR; Wirshing D; Wirshing WC
    Pharmacopsychiatry; 1998 May; 31(3):102-9. PubMed ID: 9657237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone.
    Aravagiri M; Marder SR; Nuechterlein KH; Gitlin MJ
    Ther Drug Monit; 2003 Dec; 25(6):657-64. PubMed ID: 14639051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study.
    Yoshimura R; Ueda N; Nakamura J
    Neuropsychobiology; 2001; 44(3):129-33. PubMed ID: 11586052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia].
    Baymeeva NV; Platova AI; Kaleda VG; Miroshnichenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):24-28. PubMed ID: 31089091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders.
    Jones T; Van Breda K; Charles B; Dean AJ; McDermott BM; Norris R
    Biomed Chromatogr; 2009 Sep; 23(9):929-34. PubMed ID: 19353731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paliperidone overdose with delayed onset of toxicity.
    Levine M; Lovecchio F; Tafoya P; Graham R
    Ann Emerg Med; 2011 Jul; 58(1):80-2. PubMed ID: 21376420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge.
    Taylor K; Elliott S
    Drug Test Anal; 2013; 5(9-10):748-52. PubMed ID: 23868704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
    Du J; Zhang A; Wang L; Xuan J; Yu L; Che R; Li X; Gu N; Lin Z; Feng G; Xing Q; He L
    J Psychopharmacol; 2010 Jul; 24(7):1115-20. PubMed ID: 19395426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.